Biography

Coordinator and Head of Pediatrics
Director of Translational Pediatrics and Infectious Diseases
Consultant physician in Paediatric Critical Care / Infectious Diseases
Hospital Clínico Universitario de Santiago de Compostela (Spain)

Professor in Pediatrics, University of Santiago

Coordinator, Genetics, Vaccines and Infections Research Group, GENVIP (www.genvip.org)
Clinical Coordinator, EUCLIDS, PERFORM and DIAMONDS networks (www.euclids-project.com;www.perform2020.org;www.diamonds2020.eu)
Coordinator, Spanish Meningococcal Research Network (www.esigem.com)
Coordinator, Galician Pediatric Research Network (www.regalip.org)
Coordinator, Pediatric Respiratory Infection Network (www.gendres.org)
Coordinator, Spanish Pediatric Clinical Trials Network (RECLIP - www.reclip.org)
Coordinator, WHO collaborating centre in Vaccine Safety of Santiago de Compostela (www.whochus.sergas.es)

Born in Orense (Spain) in 1971, Federico Martinón-Torres currently is consultant in Pediatrics and head of Translational Pediatrics and Infectious Diseases (Best ID unit of Spain 2019, 2020 and 2021) at the Hospital Clínico Universitario de Santiago (Spain), Associate Professor in Pediatrics (University of Santiago, Spain) and Academic of the Royal Academy of Medicine of Galicia. He graduated at the University of Santiago de Compostela and completed his medical training at the Hope Children’s Hospital of Chicago and at the Children’s Memorial Hospital of Chicago, before obtaining a PhD on the application of heliox in infants with bronchiolitis (awarded the national PhD prize). He has been granted over 25 prizes and awards to academic merits, including Best National Graduate in Medicine and Surgery (1995) and Best National Resident of all sub-specialities (2000).

He has published over 320 articles (Impact factor > 3.000 JCR 2022), 14 books and 122 chapters in refereed journals and books. He has delivered more than 1.000 lectures in over 30 countries. His main research interests are: infectious diseases, vaccines, pneumococcal diseases, bronchiolitis, meningococcal disease and heliox therapy. He is directing or involved as coordinator or lead investigator in 65 ongoing international and multicentre clinical trials and research projects, including 10 FP7/IMI/H2020 (EUCLIDS, PREPARE, PoC-ID, PERFORM, ZIKAction, RESCEU, conect4children, DIAMONDS, PROMISE and MULTILAB). Member of more than 15 national and international consultive and expert advisory boards on pneumococcal disease, RSV (ReSVinet member; www.resvinet.org), meningococcal disease, heliox, rotavirus, flu and human papillomavirus, and of over 20 professional and academic international societies. He also collaborates with WHO-Europe and presently is member of the ETAGE of WHO-Europe and coordinates the WHO collaborating centre in vaccine safety of Santiago de Compostela.

He currently coordinates the Genetics, Vaccines, and Infections Research Group (GENVIP www.genvip.org, International Zendal award in 2019) of the Healthcare Research Institute of Santiago (IDIS), the Vaccine Clinical Trials Unit of IDIS, the Clinical Network of the EUCLIDS consortium (www.euclids-project.eu), the National Research Network on Meningococcal Disease (ESIGEM - www.esigem.org), the National Research Network on Respiratory Infections and genetics (GENDRES - www.gendres.org), and the Galician Pediatric Research Network (ReGALIP – www.regalip.com) and Pneumoexperts (NEP – www.neumoexpertos.org).